Regenerative medicine and platelet rich platelet plasma therapy in NSSU clinic : clinical experience

IR Web Site Open Access

Bibliographic Information

Other Title
  • 日本体育大学クリニックにおける再生医療・多血小板血漿療法の実際
  • ニホン タイイク ダイガク クリニック ニ オケル サイセイ イリョウ ・ タケッショウバン ケッショウ リョウホウ ノ ジッサイ

Search this article

Abstract

PRP therapy is one of the biologics that uses the tissue repair and anti-inflammatory effects of many growth factors and cytokines by locally injecting platelets obtained by autologous peripheral blood aspiration. We investigated the actual data on regenerative medicine and platelet-rich plasma (PRP) therapy at the Nippon Sport and Science University Clinic. The study subjects were 1120 patients who visited the clinic and underwent PRP therapy from February 2020, when PRP was initiated, to December 2022. PRP was administered intra-articularly in 670 patients (61%) and extra-articularly in 450 patients (39%). The type of PRP was ACP in 1050 patients and PFC-FD in 70 patients. The details of the patients were as follows: 574 males and 546 females, 800 general, 157 university students, 63 professionals, 58 high school students, 21 businessmen, and 21 junior high school students. By the site of PRP injection, the knee joint accounted for 69%, elbow joint 10%, thigh 5.4%, and ankle 5.4%, in that order. By injury type, arthritis and chondritis were common in 59.7%, tendonitis in 11.8%, muscle injury in 7.1%, and ligament injury in 15.2%, in that order. The experience and good results of PRP treatment at our clinic suggest that PRP therapy is a safe and effective treatment method for muscle, ligament, and tendon injuries and intra-articular diseases and that it may allow patients to return to sports earlier than would be possible through natural processes.

Journal

Keywords

Details 詳細情報について

Report a problem

Back to top